Press Room thomsonreuters.com

A Thomson Reuters quarterly review of the latest phase changes in the pharmaceutical pipeline, this report is based on the strategic data and analysis from Thomson Pharma^®, the world’s leading pharmaceutical competitive intelligence solution.

Introduced in mid-2007, this report is the newest in the Pharma Matters series and covers the U.S. generics industry using data and analysis from Newport Premium^™, the critical product targeting the global business development system

This review takes a look at the new advances in chemistry transforming drug discovery and development, through expert insight and drawing on the strategic data from Thomson Reuters Integrity^SM, a unique database integrating biological, chemical and pharmacological data.